Testing the mettle of PBT2 for Alzheimer's disease.
Relkin
Norman R
NR
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid / Q000378:metabolism*; D017322:Clinical Trials, Phase II as Topic / Q000706:statistics & numerical data; D007464:Clioquinol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007476:Ionophores / Q000494:pharmacology*; D008670:Metals / Q000378:metabolism*; D010446:Peptide Fragments / Q000134:cerebrospinal fluid; D011804:Quinolines / Q000494:pharmacology*
D016229:Amyloid beta-Peptides; D007476:Ionophores; D008670:Metals; D010446:Peptide Fragments; D011804:Quinolines; C075222:amyloid beta-protein (1-42); D007464:Clioquinol